<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Aura Biosciences Inc (AURA)</title>
    <description>Latest news, press releases, and SEC filings for Aura Biosciences Inc (AURA)</description>
    <link>https://caymanjournal.com/stock/AURA</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 01:21:43 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/AURA/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>ARS — Aura Biosciences, Inc.</title>
      <description>⚠️ Missing Document ⚠️

It looks like the actual content of the SEC filing for Aura Biosciences, Inc. is missing. I was provided with the form type and file name, but the PDF text itself was blank.

To provide you with the deep, educational breakdown you expect—explaining the financials, the strateg</description>
      <link>https://caymanjournal.com/stock/AURA/sec-filing/0001193125-26-164048</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/AURA/sec-filing/0001193125-26-164048</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>DEF 14A — Aura Biosciences, Inc.</title>
      <description># 🧾 What This Document Is 🤖
This is a Definitive Proxy Statement for the 2026 Annual Meeting of Stockholders. Think of this document as the rulebook for your annual meeting. Its entire purpose is to inform you about the important corporate decisions the board of directors wants you, the shareholde</description>
      <link>https://caymanjournal.com/stock/AURA/sec-filing/0001193125-26-163933</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/AURA/sec-filing/0001193125-26-163933</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>8-K — Aura Biosciences, Inc.</title>
      <description># 🧾 What This Document Is
This is a **combined 8-K filing** and a press release where Aura Biosciences updates investors on its quarterly financial results and the progress of its clinical trials. Think of it as a &quot;state of the union&quot; for the company. It tells us how much money they spent, how much</description>
      <link>https://caymanjournal.com/stock/AURA/sec-filing/0001193125-26-130383</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/AURA/sec-filing/0001193125-26-130383</guid>
      <pubDate>Mon, 30 Mar 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>